Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Yung Kiang Loh"'
Autor:
Jeanette Marjorie Wood, Joy Zhu, Kantharaj Ethirajulu, Han-Chong Toh, Boon-Cher Goh, Wei-Peng Yong, Hannes Hentze, Ramesh Jayaraman, Mohammed Khalid Pasha, Yung Kiang Loh, Nina Sausgruber, Veronica Novotny-Diermayr
SB939 is an oral histone deacetylase (HDAC) inhibitor currently in phase II clinical trials potently inhibiting class I, II, and IV HDACs with favorable pharmacokinetic properties, resulting in tumor tissue accumulation. To show target efficacy, a We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2a33fd5835618140d404352e513debfa
https://doi.org/10.1158/1535-7163.c.6535455
https://doi.org/10.1158/1535-7163.c.6535455
Autor:
Jeanette Marjorie Wood, Joy Zhu, Kantharaj Ethirajulu, Han-Chong Toh, Boon-Cher Goh, Wei-Peng Yong, Hannes Hentze, Ramesh Jayaraman, Mohammed Khalid Pasha, Yung Kiang Loh, Nina Sausgruber, Veronica Novotny-Diermayr
Supplementary Methods, Figures 1-2, Tables 1-2 from Pharmacodynamic Evaluation of the Target Efficacy of SB939, an Oral HDAC Inhibitor with Selectivity for Tumor Tissue
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c67afc5b454d6b303b05ea9c843a6757
https://doi.org/10.1158/1535-7163.22496979
https://doi.org/10.1158/1535-7163.22496979
Autor:
Jeanette Marjorie Wood, Kantharaj Ethirajulu, Haishan Wang, Stefan Hart, Hannes Hentze, Kee Chuan Goh, Zahid Bonday, Yung Kiang Loh, Ai Leng Liang, Sven Pettersson, Gediminas Greicius, Pauline Yeo, Nina Sausgruber, Xiaofeng Wu, Chang Yong Hu, Kanda Sangthongpitag, Veronica Novotny-Diermayr
Supplementary Figures and Materials and Metholds from SB939, a Novel Potent and Orally Active Histone Deacetylase Inhibitor with High Tumor Exposure and Efficacy in Mouse Models of Colorectal Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65b51e86e9b7513857bdd252443925fa
https://doi.org/10.1158/1535-7163.22485351.v1
https://doi.org/10.1158/1535-7163.22485351.v1
Autor:
Jeanette Marjorie Wood, Kantharaj Ethirajulu, Haishan Wang, Stefan Hart, Hannes Hentze, Kee Chuan Goh, Zahid Bonday, Yung Kiang Loh, Ai Leng Liang, Sven Pettersson, Gediminas Greicius, Pauline Yeo, Nina Sausgruber, Xiaofeng Wu, Chang Yong Hu, Kanda Sangthongpitag, Veronica Novotny-Diermayr
Supplementary Table 2 from SB939, a Novel Potent and Orally Active Histone Deacetylase Inhibitor with High Tumor Exposure and Efficacy in Mouse Models of Colorectal Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45515ad58f3fa654f42c307ee91c362b
https://doi.org/10.1158/1535-7163.22485345
https://doi.org/10.1158/1535-7163.22485345
Autor:
Jeanette Marjorie Wood, Kantharaj Ethirajulu, Haishan Wang, Stefan Hart, Hannes Hentze, Kee Chuan Goh, Zahid Bonday, Yung Kiang Loh, Ai Leng Liang, Sven Pettersson, Gediminas Greicius, Pauline Yeo, Nina Sausgruber, Xiaofeng Wu, Chang Yong Hu, Kanda Sangthongpitag, Veronica Novotny-Diermayr
Supplementary Table 1 from SB939, a Novel Potent and Orally Active Histone Deacetylase Inhibitor with High Tumor Exposure and Efficacy in Mouse Models of Colorectal Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea26232b2120ba418d9671855d8e245c
https://doi.org/10.1158/1535-7163.22485348.v1
https://doi.org/10.1158/1535-7163.22485348.v1
Autor:
Jeanette Marjorie Wood, Kantharaj Ethirajulu, Haishan Wang, Stefan Hart, Hannes Hentze, Kee Chuan Goh, Zahid Bonday, Yung Kiang Loh, Ai Leng Liang, Sven Pettersson, Gediminas Greicius, Pauline Yeo, Nina Sausgruber, Xiaofeng Wu, Chang Yong Hu, Kanda Sangthongpitag, Veronica Novotny-Diermayr
Supplementary Table 3 from SB939, a Novel Potent and Orally Active Histone Deacetylase Inhibitor with High Tumor Exposure and Efficacy in Mouse Models of Colorectal Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab078191ad592debcca47d0ad3279d38
https://doi.org/10.1158/1535-7163.22485342.v1
https://doi.org/10.1158/1535-7163.22485342.v1
Autor:
Jeanette Marjorie Wood, Kantharaj Ethirajulu, Haishan Wang, Stefan Hart, Hannes Hentze, Kee Chuan Goh, Zahid Bonday, Yung Kiang Loh, Ai Leng Liang, Sven Pettersson, Gediminas Greicius, Pauline Yeo, Nina Sausgruber, Xiaofeng Wu, Chang Yong Hu, Kanda Sangthongpitag, Veronica Novotny-Diermayr
Although clinical responses in liquid tumors and certain lymphomas have been reported, the clinical efficacy of histone deacetylase inhibitors in solid tumors has been limited. This may be in part due to the poor pharmacokinetic of these drugs, resul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9bfd470f6ae571ff56fa8b9560145061
https://doi.org/10.1158/1535-7163.c.6531900
https://doi.org/10.1158/1535-7163.c.6531900
Autor:
Haishan Wang, Jeanette Marjorie Wood, V Novotny-Diermayr, Nina Sausgruber, Stefan Hart, Sven Pettersson, Ai Leng Liang, Gediminas Greicius, Kee Chuan Goh, Kanda Sangthongpitag, Pauline Yeo, Xiaofeng Wu, Kantharaj Ethirajulu, Chang Yong Hu, Yung Kiang Loh, Zahid Bonday, Hannes Hentze
Publikováno v:
Molecular Cancer Therapeutics. 9:642-652
Although clinical responses in liquid tumors and certain lymphomas have been reported, the clinical efficacy of histone deacetylase inhibitors in solid tumors has been limited. This may be in part due to the poor pharmacokinetic of these drugs, resul
Autor:
Ramesh Jayaraman, Wei Peng Yong, Kantharaj Ethirajulu, Yung Kiang Loh, Joy Zhu, Nina Sausgruber, Boon Cher Goh, Hannes Hentze, Mohammed Khalid Pasha, Han Chong Toh, V Novotny-Diermayr, Jeanette Marjorie Wood
Publikováno v:
Molecular cancer therapeutics. 10(7)
SB939 is an oral histone deacetylase (HDAC) inhibitor currently in phase II clinical trials potently inhibiting class I, II, and IV HDACs with favorable pharmacokinetic properties, resulting in tumor tissue accumulation. To show target efficacy, a We
Autor:
Brian W. Dymock, Jeanette Marjorie Wood, Angeline Lee, Lai Chun Ong, Kantharaj Ethirajulu, Stefan Hart, Yung Kiang Loh, Ramesh Jayaraman, Anders Poulsen, Yong Cheng Tan, Chithra Amalini, Anthony D. William, Veronica Novotny-Diermayr, Babita Madan, Kee Chuan Goh
Publikováno v:
Cancer Research. 71:3570-3570
Introduction: Janus kinase 2 (JAK2) and fms-related tyrosine kinase 3 (FLT3) are important tyrosine kinases in hematopoietic progenitor cell differentiation and proliferation. Aberrant signaling of JAK2 or FLT3 is implicated in various myeloid malign